Alan Ades
Vermögen: 29 Mio $ am 31.05.2026
Vermögen: 29 Mio $ am 31.05.2026
Alan A. Ades is the founder of A & E Stores, Inc. since 1973, holding the title of President, Chief Executive Officer & Director.
Mr. Ades is the founder of Rugby Realty LLC since 1980, holding the title of Chairman & Principal.
Former job includes Director at Organogenesis Holdings, Inc. from 2023 to 2025.
Education includes an undergraduate degree from the University of Michigan and a graduate degree from New York University School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 10.04.2026 | 11 188 363 ( 8,7 % ) | 29 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
A & E Stores, Inc.
A & E Stores, Inc. Apparel/FootwearConsumer Non-Durables Operates apparel stores | Gründer | 01.01.1973 |
Rugby Realty LLC
Rugby Realty LLC Real Estate DevelopmentFinance Operates as a real estate company | Gründer | 01.01.1980 |
| Unternehmen | Position | Ende |
|---|---|---|
| ORGANOGENESIS HOLDINGS INC. | Vorsitzender | 27.04.2023 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
A & E Stores, Inc.
A & E Stores, Inc. Apparel/FootwearConsumer Non-Durables Operates apparel stores | Consumer Non-Durables |
New York University School of Law
New York University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rugby Realty LLC
Rugby Realty LLC Real Estate DevelopmentFinance Operates as a real estate company | Finance |
Organogenesis Holdings, Inc.
Organogenesis Holdings, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and commercializes regenerative medicines products for the advanced wound care and surgical and sports medicine markets | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen